Review of the cost of venous thromboembolism

References

• GoldhaberSZBounameauxHPulmonary embolism and deep vein thrombosisLancet20123791835184622494827
   PubMed Web of Science ®Google Scholar
• WhiteRHThe epidemiology of venous thromboembolismCirculation2003107I4I812814979
   PubMed Web of Science ®Google Scholar
• LiuXPhatakHDillonRMitchellSAEpidemiology and mortality of venous thromboembolism across patient populations: a systematic literature reviewPresented at the ISPOR 18th Annual International MeetingNew Orleans, LA, USAMay, 2013 Available from: http://www.ispor.org/research_pdfs/43/pdffiles/PCV5.pdfAccessed September 17, 2013
   Google Scholar
• GalsonSKThe surgeon general’s call to action to prevent deep vein thrombosis and pulmonary embolism2008 Available from: http://www.surgeongeneral.gov/news/2008/09/pr20080915.html. http://www.ncbi.nlm.nih.gov/books/NBK44178/Accessed January 8, 2015
   Google Scholar
• HeitJACohenATFrederickAAndersonFAVTE Impact Assessment GroupEstimated annual number of incident and recurrent, non-fatal and fatal venous thromboembolism (VTE) events in the USBlood (ASH Annual Meeting Abstracts)2005106 Abstract 910
   Google Scholar
• CohenATAgnelliGAndersonFAVTE Impact Assessment Group in Europe (VITAE)Venous thromboembolism (VTE) in Europe: the number of VTE events and associated morbidity and mortalityThromb Haemost20079875676417938798
   PubMed Web of Science ®Google Scholar
• GeertsWHBergqvistDPineoGFPrevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines, 8th ednChest2008133381S453S18574271
   PubMed Web of Science ®Google Scholar
• HeitJAO’FallonWMPettersonTMRelative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based studyArch Intern Med20021621245124812038942
   PubMed Web of Science ®Google Scholar
• KnightKKWongJHauchOWygantGAguilarDOfmanJJEconomic and utilization outcomes associated with choice of treatment for venous thromboembolism in hospitalized patientsValue Health2005819120015877591
   PubMed Web of Science ®Google Scholar
• FanikosJRaoASegerACCarterDPiazzaGGoldhaberSZHospital costs of acute pulmonary embolismAm J Med201312612713223331440
   PubMed Web of Science ®Google Scholar
• BonafedeMMShorrAFJohnsonBHHorblyukRFondaparinux is economically non-inferior to enoxaparin for the treatment of venous thromboembolismValue Health200912A142
   Web of Science ®Google Scholar
• MerliGFerrufinoCLinJHusseinMBattlemanDHospital-based costs associated with venous thromboembolism treatment regimensJ Thromb Haemost200861077108618445118
   PubMed Web of Science ®Google Scholar
• MerliGFerrufinoCPLinJHusseinMBattlemanDHospital-based costs associated with venous thromboembolism prophylaxis regimensJ Thrombosis Thrombolysis201029449458
   PubMed Web of Science ®Google Scholar
• O’BrienJACaroJJDirect medical cost of managing deep vein thrombosis according to the occurrence of complicationsPharmacoeconomics20022060361512141888
   PubMed Web of Science ®Google Scholar
• BullanoMFWilleyVHauchOWygantGSpyropoulosACHoffmanLLongitudinal evaluation of health plan cost per venous thromboembolism or bleed event in patients with a prior venous thromboembolism event during hospitalizationJ Manag Care Pharm20051166367316194130
   PubMedGoogle Scholar
• SpyropoulosACLinJDirect medical costs of venous thromboembolism and subsequent hospital readmission rates: An administrative claims analysis from 30 managed care organizationsJ Manag Care Pharm20071347548617672809
   PubMed Web of Science ®Google Scholar
• HeitJAMohrDNSilversteinMDPettersonTMO’FallonWMMeltonLJ3rdPredictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort studyArch Intern Med200016076176810737275
   PubMed Web of Science ®Google Scholar
• RuppertASteinleTLeesMEconomic burden of venous thromboem-bolism: a systematic reviewJ Med Econ201114657421222564
   PubMedGoogle Scholar
• LinJPreblickRLingohr-SmithMKwongWJIncremental healthcare resource utilization and economic burden of venous thromboembo-lism recurrence from a US payer perspectiveJ Manag Care Pharm20142017418624456319
   PubMed Web of Science ®Google Scholar
• MacDougallDAFeliuALBoccuzziSJLinJEconomic burden of deep-vein thrombosis, pulmonary embolism, and post-thrombotic syndromeAm J Health-Syst Ph20066320 supplS5S15
   Google Scholar
• LefebvrePLalibertéFNutescuEAAll-cause and potentially disease-related health care costs associated with venous thromboembolism in commercial, Medicare, and Medicaid beneficiariesJ Manag Care Pharm20121836337422663169
   PubMedGoogle Scholar
• GroceJBIIIPatient outcomes and cost analysis associated with an outpatient deep venous thrombosis treatment programPharmacotherapy199818175S180S9853912
   PubMedGoogle Scholar
• TillmanDJCharlandSLWittDMEffectiveness and economic impact associated with a program for outpatient management of acute deep vein thrombosis in a group model health maintenance organizationArch Intern Med20001602926293211041899
   PubMed Web of Science ®Google Scholar
• YeagerBFMathernySCLow-molecular-weight heparin in outpatient treatment of DVTAm Fam Physician199959494595210068716
   PubMed Web of Science ®Google Scholar
• BlattlerWGerlachHEImplementation of outpatient treatment of deep-vein thrombosis in private practices in GermanyEur J Vasc Endovasc Surg200530331932415949958
   PubMed Web of Science ®Google Scholar
• KrogerKKupper-NybelenJMoerchelCMoysidisTKienitzCSchubertIPrevalence and economic burden of pulmonary embolism in GermanyVasc Med (United Kingdom)201217303309
   Google Scholar
• AnnemansLRobaysHBruartJVerstraetenPVariation in medical resource utilization in the management of pulmonary embolism in BelgiumActa Clin Belg200257111812017750
   PubMed Web of Science ®Google Scholar
• GussoniGFogliaEFrassonSon behalf of the FADOI Permanent Study Group on Clinical GovernanceReal-world economic burden of venous thromboembolism and antithrombotic prophylaxis in medical inpatientsThromb Res2013131172323141845
   PubMed Web of Science ®Google Scholar
• GuanellaRDucruetTJohriMEconomic burden and cost determinants of deep vein thrombosis during 2 years following diagnosis: a prospective evaluationJ Thromb Haemost201192397240521951970
   PubMed Web of Science ®Google Scholar
• TilleulPLaFumaAColinXOzierYEstimated annual costs of prophylaxis and treatment of venous thromboembolic events associated with major orthopedic surgery in FranceClin Appl Thromb-Hem200612473484
   PubMed Web of Science ®Google Scholar
• Bureau of Labor StatisticsUnited States Department of LaborArchived Consumer Price Index detailed report information Available from: http://www.bls.gov/cpi/cpi_dr.htm#2001Accessed March 28, 2014
   Google Scholar
• GaleandroAIQuistelliGScicchitanoPDoppler ultrasound venous mapping of the lower limbsVasc Health Risk Manag20128596422371652
   PubMedGoogle Scholar
• GaleandroAIScicchitanoPZitoAA three-dimensional electronic report of a venous echo color Doppler of the lower limbs: MEVeC®Vasc Health Risk Manag20141054955525214793
   PubMedGoogle Scholar
• PrinsMHLensingAWBauersachsROral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studiesThromb J20131112124053656
   PubMedGoogle Scholar
• AgnelliGBullerHRCohenAOral apixaban for the treatment of acute venous thromboembolismN Engl J Med2013369979980823808982
   PubMed Web of Science ®Google Scholar
• BüllerHRDécoususHGrossoMAEdoxaban versus warfarin for the treatment of symptomatic venous thromboembolismN Engl J Med2013369151406141523991658
   PubMed Web of Science ®Google Scholar
• SchulmanSKakkarAKGoldhaberSZTreatment of acute venous thromboembolism with dabigatran or warfarin and pooled analysisCirculation2014129776477224344086
   PubMed Web of Science ®Google Scholar
• SchulmanSKearonCKakkarAKDabigatran versus warfarin in the treatment of acute venous thromboembolismN Engl J Med2009361242342235219966341
   PubMed Web of Science ®Google Scholar
• AndersonJLHeidenreichPABarnettPGACC/AHA Statement on Cost/Value Methodology in Clinical Practice Guidelines and Performance Measures: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice GuidelinesCirculation2014129222329234524677315
   PubMed Web of Science ®Google Scholar
• SánchezFSLBolumburuAAAQuality of life and venous thromboem-bolic disease]. [Article in SpanishMed Clin (Barc)200811131Suppl 23741
   Google Scholar
• KlokFAvan KralingenKWvan DijkAPQuality of life in long-term survivors of acute pulmonary embolismChest20101381432144020495104
   PubMed Web of Science ®Google Scholar